Tempus Pixel vs EchoGo® Heart Failure
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tempus Pixel is a multi-modality AI imaging platform designed for broad diagnostic analysis across cardiology, oncology, and neurology. In contrast, EchoGo® Heart Failure is a highly specialized AI tool focused exclusively on detecting HFpEF from echocardiograms. While both operate in Cardiology AI, Tempus Pixel offers a general imaging solution, whereas EchoGo® provides a targeted diagnostic aid for a specific cardiac condition.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Tempus Pixel is an AI-powered platform for medical imaging analysis across cardiology, oncology, and neurology, supporting multi-modality imaging including MRI, CT, X-ray, and ultrasound. EchoGou00ae Heart Failure is an AI platform specifically designed to analyze routine echocardiograms for the detection of Heart Failure with preserved Ejection Fraction (HFpEF).
Tempus Pixel requires contacting the company for a quote. EchoGou00ae Heart Failure is a paid platform, reimbursable via CPT code 0932T for outpatient analysis with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers.
Tempus Pixel is cloud-based and integrates with existing PACS, EHR, and RIS environments. EchoGou00ae Heart Failure is also cloud-based and offers seamless integration with existing workflows and IT stacks, including DICOM workflow for report delivery to PACS.
Tempus Pixel offers AI-powered analysis, real-time collaboration, 3D visualization, quantitative analysis, and automated reporting across multiple modalities. EchoGou00ae Heart Failure provides AI-powered HFpEF detection with insights delivered within 20 minutes, automated structured reports, and is clinically validated with 90% sensitivity and 86% specificity for HFpEF, trained on over 10 years of outcome data.
EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF, and its AI model was trained on over 10 years of outcome data. Tempus Pixel enhances diagnostic accuracy and workflow efficiency, and has received FDA 510(k) clearances for its cardiac MR image analysis, including generating T1 and T2 inline maps.
Tempus Pixel targets radiologists and clinicians across cardiology, oncology, and neurology. EchoGou00ae Heart Failure is specifically designed for cardiology, emergency medicine, and internal medicine, focusing on HFpEF detection.